Anti-CRMP3 antibody [EPR7591]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal CRMP3 antibody. Suitable for WB and reacts with Human samples. Cited in 1 publication.
View Alternative Names
CRMP3, ULIP4, DPYSL4, Dihydropyrimidinase-related protein 4, DRP-4, Collapsin response mediator protein 3, UNC33-like phosphoprotein 4, CRMP-3, ULIP-4
- WB
Unknown
Western blot - Anti-CRMP3 antibody [EPR7591] (AB133287)
All lanes:
Western blot - Anti-CRMP3 antibody [EPR7591] (ab133287)
Lane 1:
U87-MG at 10 µg
Lane 2:
human cerebellum lysate at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 62 kDa
false
Related conjugates and formulations (1)
-
Anti-CRMP3 antibody [EPR7591] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Molecular medicine reports 26: PubMed35795990
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com